What is the main business of Cannabibs?

The main business activity of Cannabibs focuses on other research and experimental development on natural sciences and engineering.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 7, 2023.

Where is the headquarters located?

The headquarters is located at: ul. Marszałkowska 58, 00-545 Warszawa.

What is the share capital?

The share capital of the company is PLN 6,900 (approx. $1,864).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

The company reported a revenue of $5,897 in 2024, which is an increase of 1517.0% compared to 2023.

Is the company profitable?

No, the company recorded a net loss of $26,448 in 2024. For comparison, in 2023 the loss was $3,885, meaning the company increased its loss by 546.5%.

What is the main operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $13,855 in 2024, representing 44% of all operating expenses.

Cannabibssp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2023-03-07

Share capital

6 900,00 PLN

Activity description

Cannabibs conducts cannabinoid research to establish safety and efficacy and prepare commercialisation compliant with FDA, EMA and MHRA requirements. The company holds an exclusive licence from Green Space Labs Inc. for a line of cannabinoid-based substances; it has clearance for a Phase 2 trial of GSL01-001 in patients with diarrhoea-predominant IBS and aims to introduce an over-the-counter medicine in the EU and UK markets.

Registered address

ul. Marszałkowska 58/15, 00-545 Warszawa, Poland

Website

cannabibs.eu

Phone

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 5.90kMedianUSD 72.17kAverageUSD 3.24m

Net profit

This companyUSD -26.45kMedianUSD 120.67AverageUSD 92.92k

Operating costs

This companyUSD 31.84kMedianUSD 75.89kAverageUSD 3.04m

Assets

This companyUSD 252.89kMedianUSD 121.07kAverageUSD 3.90m

Industry

Bank accounts

Registered as a VAT taxpayer on 2023-04-27. Active

No bank accounts reported to the VAT Taxpayer Register.

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

Grant date	Purpose	Gross amount	Granting body
Mar 31, 2022	Aid for SME access to finance — aid for start-ups	$168.7K$168,686	Dyrektor Narodowego Centrum Badań i Rozwoju

Tenders

No recorded participation in tenders.

Authorized Representatives

William Albro – President of the Management Board

Richard Bailey – Management Board Member

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Greenspace Labs Inc., Spółka Prawa Amerykańskiego	90	$1,215.56	65.2174%
Medi Ventures sp. z o.o. + limited partnership	34	$459.21	24.6377%
Leo Turno (58)	14	$189.09	10.1449%

Beneficial owners

Person	Rights
Leo Turno (58)	Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).

Competitors

	Name	Revenue	Website
	CannamedaiS.A.	$28,203.90	cannamedai.com
	Microbiota Medsp. z o.o.	$7,423.69	microbiota-med.com

Change history

Date	Event
2023-08-04	Share capital change (5,000.00 PLN → 6,900.00 PLN)
2023-03-07	Entered in the register

FAQ

Last updated: 2026-04-20